{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"Matinas Biopharma Holdings, Inc."},"Symbol":{"label":"Symbol","value":"MTNB"},"Address":{"label":"Address","value":"1545 ROUTE 206 SOUTH,SUITE 302, BEDMINSTER, New Jersey, 07921, United States"},"Phone":{"label":"Phone","value":"+1 908 484-8805"},"Industry":{"label":"Industry","value":"Biotechnology: Pharmaceutical Preparations"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"North America"},"CompanyDescription":{"label":"Company Description","value":"Matinas BioPharma Holdings Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of product candidates derived from its lipid-crystal nano-particle, or cochleate, delivery technology platform. The firm's pipeline includes MAT2203, MAT2501 and others."},"CompanyUrl":{"label":"Company Url","value":"https://www.matinasbiopharma.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"Jerome D. Jabbour","title":"President, Chief Executive Officer & Director"},{"name":"Susan Johansson","title":"Vice President-Clinical Development"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}